Literature DB >> 11152482

CD154 costimulated ovine primary B cells, a cell culture system that supports productive infection by bovine leukemia virus.

A Van den Broeke1, Y Cleuter, T Beskorwayne, P Kerkhofs, M Szynal, C Bagnis, A Burny, P Griebel.   

Abstract

Bovine leukemia virus (BLV) is closely associated with the development of B-cell leukemia and lymphoma in cattle. BLV infection has also been studied extensively in an in vivo ovine model that provides a unique system for studying B-cell leukemogenesis. There is no evidence that BLV can directly infect ovine B cells in vitro, and there are no direct data regarding the oncogenic potential of the viral Tax transactivator in B cells. Therefore, we developed ovine B-cell culture systems to study the interaction between BLV and its natural target, the B cell. In this study, we used murine CD154 (CD40 ligand) and gamma-chain-common cytokines to support the growth of B cells isolated from ovine lymphoid tissues. Integrated provirus, extrachromosomal forms, and viral transcripts were detected in BLV-exposed populations of immature, rapidly dividing surface immunoglobulin M-positive B cells from sheep ileal Peyer's patches and also in activated mature B cells isolated from blood. Conclusive evidence of direct B-cell infection by BLV was obtained through the use of cloned B cells derived from sheep jejunal Peyer's patches. Finally, inoculation of sheep with BLV-infected cultures proved that infectious virus was shed from in vitro-infected B cells. Collectively, these data confirm that a variety of ovine B-cell populations can support productive infection by BLV. The development of ovine B-cell cultures permissive for BLV infection provides a controlled system for investigating B-cell leukemogenic processes and the pathogenesis of BLV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152482      PMCID: PMC114015          DOI: 10.1128/JVI.75.3.1095-1103.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  The immunophenotypic characterization of bovine lymphomas.

Authors:  W Vernau; R M Jacobs; V E Valli; J L Heeney
Journal:  Vet Pathol       Date:  1997-05       Impact factor: 2.221

2.  Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51.

Authors:  D Portetelle; M Mammerickx; A Burny
Journal:  J Virol Methods       Date:  1989-02       Impact factor: 2.014

3.  Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity.

Authors:  D Derse; L Martarano
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

Review 4.  Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection.

Authors:  G Franchini
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

5.  Unintegrated bovine leukemia virus DNA: association with viral expression and disease.

Authors:  R A Reyes; G L Cockerell
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  CD40 signaling induces B cell responsiveness to multiple members of the gamma chain-common cytokine family.

Authors:  P Griebel; T Beskorwayne; A Van den Broeke; G Ferrari
Journal:  Int Immunol       Date:  1999-07       Impact factor: 4.823

7.  Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis.

Authors:  F Dequiedt; E Hanon; P Kerkhofs; P P Pastoret; D Portetelle; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.

Authors:  M L Mirsky; C A Olmstead; Y Da; H A Lewin
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.

Authors:  A Van Den Broeke; C Bagnis; M Ciesiolka; Y Cleuter; H Gelderblom; P Kerkhofs; P Griebel; P Mannoni; A Burny
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  A novel molecular complex expressed on immature B cells: a possible role in T cell-independent B cell development.

Authors:  P J Griebel; P Ghia; U Grawunder; G Ferrari
Journal:  Dev Immunol       Date:  1996
View more
  5 in total

1.  Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells.

Authors:  Pavel Klener; Maud Szynal; Yvette Cleuter; Makram Merimi; Hugues Duvillier; Françoise Lallemand; Claude Bagnis; Philip Griebel; Christos Sotiriou; Arsène Burny; Philippe Martiat; Anne Van den Broeke
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

3.  No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms.

Authors:  Thomas Burmeister; Stefan Schwartz; Michael Hummel; Dieter Hoelzer; Eckhard Thiel
Journal:  Retrovirology       Date:  2007-02-07       Impact factor: 4.602

Review 4.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

5.  Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells.

Authors:  Jerome S Harms; Kurt A Eakle; Lillian S Kuo; Robert D Bremel; Gary A Splitter
Journal:  Genet Vaccines Ther       Date:  2004-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.